| Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. | |
| | |
MedLine Citation:
|
PMID: 15231951 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Jaundice occurs in most newborn infants. Most jaundice is benign, but because of the potential toxicity of bilirubin, newborn infants must be monitored to identify those who might develop severe hyperbilirubinemia and, in rare cases, acute bilirubin encephalopathy or kernicterus. The focus of this guideline is to reduce the incidence of severe hyperbilirubinemia and bilirubin encephalopathy while minimizing the risks of unintended harm such as maternal anxiety, decreased breastfeeding, and unnecessary costs or treatment. Although kernicterus should almost always be preventable, cases continue to occur. These guidelines provide a framework for the prevention and management of hyperbilirubinemia in newborn infants of 35 or more weeks of gestation. In every infant, we recommend that clinicians 1) promote and support successful breastfeeding; 2) perform a systematic assessment before discharge for the risk of severe hyperbilirubinemia; 3) provide early and focused follow-up based on the risk assessment; and 4) when indicated, treat newborns with phototherapy or exchange transfusion to prevent the development of severe hyperbilirubinemia and, possibly, bilirubin encephalopathy (kernicterus). |
| | |
Authors:
|
|
Publication Detail:
|
Type: Guideline; Journal Article; Practice Guideline |
Journal Detail:
|
Title: Pediatrics Volume: 114 ISSN: 1098-4275 ISO Abbreviation: Pediatrics Publication Date: 2004 Jul |
Date Detail:
|
Created Date: 2004-07-02 Completed Date: 2004-09-30 Revised Date: 2009-09-29 |
Medline Journal Info:
|
Nlm Unique ID: 0376422 Medline TA: Pediatrics Country: United States |
Other Details:
|
Languages: eng Pagination: 297-316 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Algorithms Bilirubin / blood Breast Feeding Exchange Transfusion, Whole Blood Humans Infant, Newborn Infant, Premature Infant, Premature, Diseases / therapy Jaundice, Neonatal / etiology, prevention & control, therapy* Kernicterus / prevention & control* Phototherapy* Risk Assessment Terminology as Topic |
| Chemical | |
Reg. No./Substance:
|
635-65-4/Bilirubin |
| Comments/Corrections | |
Comment In:
|
Pediatrics. 2004 Oct;114(4):1086-8
[PMID:
15466110
]
Pediatrics. 2004 Oct;114(4):1134-5; author reply 1135-7 [PMID: 15466132 ] Pediatrics. 2004 Aug;114(2):494-6 [PMID: 15286239 ] Pediatrics. 2009 Oct;124(4):1193-8 [PMID: 19786452 ] Pediatrics. 2005 Mar;115(3):824-5 [PMID: 15741399 ] Pediatrics. 2006 Jan;117(1):262-3 [PMID: 16396898 ] |
Erratum In:
|
Pediatrics. 2004 Oct;114(4):1138 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cerebral metabolism in severe neonatal hyperbilirubinemia.
Next Document: E-mail communication between pediatricians and their patients.